Has Erick Kazarian, MD received payments from drug or device companies?

Yes. Drug and device makers reported $48,028 in general payments to Erick Kazarian, MD across 146 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Erick Kazarian, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Erick Kazarian, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Erick Kazarian, MD

Orthopaedic Surgery · Harrison, NYNPI 1538515432

Payments from drug & device makers

$48,028in general payments, 2019–2025

Across 146 payments — averaging $328.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Cerapedics Inc.$28K
Stryker$5K
Medtronic$3K
Amplify Surgical, Inc.$3K
Globus Medical$2K
Acuity Surgical Devices, LLC$2K
plus $6K from 19 others

$500in research payments, 2019–2025

Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

GS Solutions, Inc.$500

What the payments were for

Consulting fees$29,27061%
Travel & lodging$7,33415%
Food & beverage$11,14523%
Education$2791%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Cerapedics Inc.	25	$28,344
Stryker	19	$4,845
Medtronic	30	$2,673
Amplify Surgical, Inc.	3	$2,628
Globus Medical(2 entities)	14	$1,968
Acuity Surgical Devices, LLC	3	$1,812
4web, Inc.	9	$1,297
Johnson & Johnson	10	$673
Arteriocyte Medical Systems, Inc.	1	$664
Synthes GmbH	1	$541
Alphatec Spine, Inc	2	$505
Orthofix Medical, Inc.	11	$368
Carlsmed, Inc.	2	$234
Medical Device Business Services, Inc.	2	$233
Intrinsic Therapeutics	2	$225
Si-bone, Inc.	1	$161
MML US, Inc.	1	$153
Kuros Biosciences USA, Inc	1	$147
Saluda Medical Americas, Inc.	2	$145
GS Solutions, Inc.	1	$131
Amgen	1	$122
Zimmer Biomet	2	$71
Providence Medical Technology, Inc.	1	$52
Relievant Medsystems, Inc.	1	$20
Abbott	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

I-FACTOR PEPTIDE ENHANCED BONE GRAFT$27,767
dualPortal$1,500
EVEREST SPINAL SYSTEM$1,272
SPINE TRUSS SYSTEM$1,193
dualX$1,000
ExcelsiusGPS Robotic Navigation System$927
INTELLIS ADAPTIVESTIM$853
XLIF$778
Magellan$664
Other - Miscellaneous$505
CASCADIA INTERBODY SYSTEM$441
BARRICAID ACD (ANNULAR CLOSURE DEVICE)$424
FIBERGRAFT BG Morsels$419
CAPRI CORPECTOMY CAGE SYSTEM$282
aprevo$207
CATALYFT PL EXPANDABLE INTERBODY SYSTEM$177
UNID_PASS$171
MAZOR X SYSTEM$170
Cervical-STIM$156
ARTIC-L 3D TI SPINAL SYSTEM WITH TIONIC TECHNOLOGY$155

How this compares

$48,028 in reported general payments places this provider in the 80th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$64,535

Medicare patients

Services billed

310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	24	$346
Methylprednisolone	12	$91
Meloxicam	26	$72

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Harrison

Anthony RomeoNew York$27M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$14.1M
William RicciNew York$11.6M
Steven HaasNew York$11.5M
Giles ScuderiNew York$10.9M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$8M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →